A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Public ClinicalTrials.gov record NCT02517554. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.
Study identification
- NCT ID
- NCT02517554
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site Behavioral
- Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site Behavioral
- Patient receives written information on how to find genetic services in their area Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2015
- Primary completion
- Feb 28, 2018
- Completion
- Oct 31, 2019
- Last update posted
- Jan 18, 2024
2015 – 2019
United States locations
- U.S. sites
- 7
- U.S. states
- 3
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Union Hospital | Elkton | Maryland | 21921 | — |
| Cape Regional Medical Center | Cape May Court House | New Jersey | 08210 | — |
| Kennedy Health | Sewell | New Jersey | 08080 | — |
| Shore Cancer Center | Somers Point | New Jersey | 08244 | — |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | — |
| Drexel Cancer Care at Hahnemann | Philadelphia | Pennsylvania | 19102 | — |
| Abramson Cancer Center of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02517554, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2024 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02517554 live on ClinicalTrials.gov.